World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
26485
World Ranking
1259
National Ranking
37

Medicine

D-Index
80
Citations
28816
World Ranking
16968
National Ranking
710

Mel Krajden publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mel Krajden sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 395 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mel Krajden D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mel Krajden sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mel Krajden is affiliated with the University of British Columbia in Canada and has contributed extensively to the field of medicine, with a particular focus on infectious diseases. Their research spans over 367 publications, including significant work in epidemiology, hepatology, oncology, and molecular biology.

Their main areas of study include infectious diseases with 138 publications, epidemiology with 115, and hepatology accounting for 59 papers. Additional subfields include oncology and molecular biology, reflecting a broad interest in medical science.

Krajden's research covers a range of topics, prominently including SARS-CoV-2 and COVID-19 research with 112 publications, hepatitis C virus research documented in 92 papers, and liver disease diagnosis and treatment with 66 studies. Other notable topics are hepatitis B virus studies, SARS-CoV-2 detection and testing, COVID-19 clinical research studies, and studies related to HIV, drug use, and sexual risk behaviors.

Their recent influential papers include:

  • "Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories" (2020) published in Journal of Clinical Virology
  • "Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada" (2022) in Clinical Infectious Diseases
  • "Global phylogeny of Treponema pallidum lineages reveals recent expansion and spread of contemporary syphilis" (2021) in Nature Microbiology
  • "SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health" (2020) in Canadian Medical Association Journal
  • "Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada" (2022) in Canadian Medical Association Journal

Frequent collaborators in Krajden's work include:

  • Naveed Z. Janjua
  • Sofia Bartlett
  • Stanley Wong
  • Amanda Yu
  • Mawuena Binka

Key publication venues where Krajden has frequently published are:

  • Journal of Hepatology (21 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (15 publications)
  • Clinical Infectious Diseases (7 publications)
  • Open Forum Infectious Diseases (6 publications)
  • Canadian Medical Association Journal (5 publications)

Best Publications

  • The Genome Sequence of the SARS-associated Coronavirus

    Marco A. Marra;Steven J. M. Jones;Caroline R. Astell;Robert A. Holt

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Identification of Severe Acute Respiratory Syndrome in Canada

    Susan M. Poutanen;Susan M. Poutanen;Donald E. Low;Bonnie Henry;Sandy Finkelstein

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

    Unknown

  • Human illness from avian influenza H7N3, British Columbia.

    S. Aleina Tweed;Danuta M. Skowronski;Samara T. David;Andrew Larder

  • Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

    Simon R. M. Dobson;Shelly McNeil;Marc Dionne;Meena Dawar

  • Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc

  • Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting

    Julio S.G. Montaner;Viviane D. Lima;P. Richard Harrigan;Lillian Lourenço

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

    Gina Suzanne Ogilvie;Dirk van Niekerk;Mel Krajden;Laurie W. Smith

  • Novel avian influenza H7N3 strain outbreak, British Columbia

    Martin Hirst;Caroline R Astell;Malachi Griffith;Shaun M. Coughlin

  • Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.

    Atul Humar;Daniel Gregson;Angela M. Caliendo;Allison McGeer

  • Strategies to manage hepatitis C virus (HCV) disease burden

    H Wedemeyer;A S Duberg;M Buti;W M Rosenberg

  • A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season

    Danuta M. Skowronski;Catharine Chambers;Suzana Sabaiduc;Gaston De Serres

  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

    Unknown

  • Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis

    Carole Ann Lunny;Darlene Taylor;Linda Hoang;Tom Wong

  • Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

    J. Grebely;J. D. Raffa;C. Lai;M. Krajden

  • Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study

    Art F Y Poon;Réka Gustafson;Patricia Daly;Laura Zerr

  • The laboratory diagnosis of hepatitis B virus.

    Mel Krajden;Gail McNabb;Martin Petric

  • An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus

    David M Patrick;Martin Petric;Danuta M Skowronski;Roland Guasparini

  • Burden of disease and cost of chronic hepatitis C virus infection in Canada

    Robert P Myers;Mel Krajden;Marc Bilodeau;Kelly Kaita

Frequent Co-Authors

Mark W. Tyndall
Mark W. Tyndall University of British Columbia
Danuta M. Skowronski
Danuta M. Skowronski University of British Columbia
Yan Li
Yan Li Public Health Agency of Canada
Martin Petric
Martin Petric University of British Columbia
Jane A. Buxton
Jane A. Buxton University of British Columbia
Jason Grebely
Jason Grebely University of New South Wales
Nathalie Bastien
Nathalie Bastien Public Health Agency of Canada
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
Jonathan B. Gubbay
Jonathan B. Gubbay BC Children's Hospital Foundation
Hugues Charest
Hugues Charest University of Montreal

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in exploring further education alongside microbiology, understanding what medical degree can I get online is crucial. Many medical-related degrees are now accessible through flexible online programs, allowing students to balance studies with other commitments.

Public health is a closely related field, and many professionals pursue an MPH to broaden their career options. If the admission process seems intimidating, reviewing the list of easy admission online MPH programs can provide helpful guidance for finding accessible pathways.

For graduates interested in impactful healthcare roles, becoming a child life specialist offers rewarding opportunities. Those curious about this path should understand the child life specialist salary and job requirements before making a commitment.

Additionally, individuals with past convictions seeking a fresh start might find guidance by exploring what is the best degree for a convicted felon. Online programs focused on accessible education can open doors to new careers and opportunities in microbiology-related fields and beyond.

Best Scientists Citing Mel Krajden

Trending Scientists

Recently Published Articles